Caption Management’s Ascendis Pharma A/S ASND Stock Holding History

Caption Management’s Portfolio ASND Stock Details ASND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-102,500	Closed	-$21.9M	–	1543
2025 Q4	$21.9M	Buy	102,500 +87,600	+588%	+$18.1M	0.15%	156
2025 Q3	$2.96M	Sell	14,900 -5,100	-26%	-$951K	0.02%	674
2025 Q2	$3.45M	Sell	20,000 -10,000	-33%	-$1.63M	0.04%	525
2025 Q1	$4.68M	Hold	30,000	–	–	0.05%	415
2024 Q4	$4.13M	Buy	30,000 +17,500	+140%	+$2.3M	0.04%	429
2024 Q3	$1.87M	Buy	12,500 +5,400	+76%	+$729K	0.03%	585
2024 Q2	$968K	Sell	7,100 -42,900	-86%	-$5.84M	0.01%	669
2024 Q1	$7.56M	Buy	+50,000	New	+$7.14M	0.11%	223
2023 Q3	–	Sell	-32,500	Closed	-$2.9M	–	1262
2023 Q2	$2.9M	Buy	32,500 +7,500	+30%	+$653K	0.05%	411
2023 Q1	$2.68M	Hold	25,000	–	–	0.05%	376
2022 Q4	$3.05M	Buy	25,000 +3,000	+14%	+$348K	0.05%	444
2022 Q3	$2.27M	Buy	+22,000	New	+$2.09M	0.03%	594
2022 Q2	–	Sell	-25,000	Closed	-$2.93M	–	1437
2022 Q1	$2.93M	Buy	25,000 +5,000	+25%	+$579K	0.04%	608
2021 Q4	$2.69M	Hold	20,000	–	–	0.03%	680
2021 Q3	$3.19M	Sell	20,000 -150,300	-88%	-$20.6M	0.04%	601
2021 Q2	$22.4M	Buy	170,300 +131,500	+339%	+$17.5M	0.29%	64
2021 Q1	$5M	Buy	+38,800	New	+$5.9M	0.11%	246

Other funds holding ASND

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Caption Management's ASND Position: Q2 2026 in Review

Caption Management opened a new position in Ascendis Pharma A/S (ASND) in Q2 2026: 25,500 shares worth $6.8M. The stake represents 0.03% of the portfolio and ranks #500 among its holdings. This is a return to the name: Caption Management previously reported a position in ASND as recently as Q2 2025.

Caption Management first reported a position in ASND in Q3 2019 and has held it in 11 quarters since. 312 funds tracked by Wall St. Rank hold ASND as of Q2 2026.

Caption Management held 25,500 shares of Ascendis Pharma A/S worth $6.8M as of Q2 2026.
Ascendis Pharma A/S was a new Caption Management position in Q2 2026.
Ascendis Pharma A/S made up 0.03% of Caption Management's portfolio in Q2 2026, its #500 holding.
Caption Management first reported a position in Ascendis Pharma A/S in Q3 2019 and has held it in 11 quarters since.
312 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q2 2026.

Based on Caption Management's 13F filing for Q2 2026, filed 14 Aug 2026.